Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net income (loss)	$ 1,465,091	$ (2,981,947)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	394,976	792,104
Amortization of deferred gain on sale/leaseback	0	(45,700)
Amortization of ROU Asset	359,564	470,771
Realized currency translation gain	(92,282)	0
Gain on forgiveness of PPP Funding	0	(1,047,700)
Gain on sale of building	(3,356,794)	0
Provision for losses on accounts receivable	154,301	20,666
Provision for losses on inventories	0	(40,482)
Impairment of Note Receivable	95,000	350,000
Change in assets and liabilities:
Accounts receivable	(51,654)	2,915,506
Inventories	(551,065)	2,314,744
Prepaid expenses and other assets	(843,581)	(289,820)
Change in ROU Liability	(359,564)	(470,771)
Trade payables	(833,554)	(852,231)
Accrued liabilities	680,223	(140,076)
Net cash provided by (used in) operating activities	(2,939,339)	995,064
Cash flows from investing activities:
Purchases of property, plant and equipment	(98,824)	(139,708)
Sale of building	3,500,000	0
Net cash provided by (used in) investing activities	3,401,176	(139,708)
Cash flows from financing activities:
Change in checks written in excess of bank balance	0	29,837
Repayment of debt and revolving line of credit	(3,729,577)	(10,158,387)
Proceeds from advance from investor	1,500,000	1,500,000
Proceeds from issuance of stock	0	5,426,601
Cash paid for stock issuance costs	0	(1,024,313)
Cash paid for deferred financing fees	85,492	64,887
Proceeds from PPP	0	1,047,700
Proceeds from issuance of long-term debt and revolving line of credit	1,494,227	876,791
Net cash used in financing activities	(649,858)	(2,236,884)
Effect of exchange rate changes on cash	(11,416)	536,430
Net decrease in cash and cash equivalents	(199,437)	(845,098)
Cash and cash equivalents at beginning of period	624,953	845,098
Supplemental disclosure of cash flow information:
Cash payments for interest	526,700	1,033,350
Accrued Divided and Accretion on preferred stock	544,876	255,000
Issuance of Placement agent warrants in connection with Series A Preferred offering	0	919,000
Cash receipts for tax refund	206,000	0
Amortization of beneficial conversion feature and deemed dividend on Preferred stock	1,500,000	2,200,000
Stock Placement Agent [Member]
Supplemental disclosure of cash flow information:
Stock issued	0	306,000
Conversion of Debt to Series A Preferred [Member]
Supplemental disclosure of cash flow information:
Conversion of debt to Series A Preferred	0	478,000
Series B Preferred Stock [Member]
Cash flows from financing activities:
Cash and cash equivalents at end of period	425,516	0
Series C Preferred Stock [Member]
Supplemental disclosure of cash flow information:
Stock issued	$ 1,500,000	$ 0